Transgenic mouse model of pharmacologic induction of fetal hemoglobin: Studies using a new ribonucleotide reductase inhibitor, didox
- 1 February 1994
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 45 (2) , 136-141
- https://doi.org/10.1002/ajh.2830450208
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin DisordersNew England Journal of Medicine, 1993
- On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraCBlood, 1989
- The human beta-globin locus activation region alters the developmental fate of a human fetal globin gene in transgenic mice.Proceedings of the National Academy of Sciences, 1989
- alpha-Amino-N-butyric acid stimulates fetal hemoglobin in the adultBlood, 1988
- Stimulation of Fetal Hemoglobin Synthesis by Erythropoietin in BaboonsNew England Journal of Medicine, 1987
- Stimulation of F-Cell Production in Patients with Sickle-Cell Anemia Treated with Cytarabine or HydroxyureaNew England Journal of Medicine, 1985
- Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.Journal of Clinical Investigation, 1984
- Augmentation of Fetal-Hemoglobin Production in Anemic Monkeys by HydroxyureaNew England Journal of Medicine, 1984
- 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+ThalassemiaNew England Journal of Medicine, 1982
- 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.Proceedings of the National Academy of Sciences, 1982